Introduction
Anastomotic leakages are a specific complication after major surgery of the upper gastrointestinal tract. They are associated with increased mortality and prolonged stay in the intensive care unit. Due to its nature as an unintended severe adverse event, there are nearly no prospective trials about the management of anastomotic leakages. Thus, there is only limited evidence based on retrospective case series and expert experience.
Endoscopic Assessment of Anastomosis
Endoscopy plays an important role in making the diagnosis as well as regarding the treatment of anastomotic leakages after upper 
Characteristics of Endoscopic Findings
The most important advantage of endoscopic inspection of the anastomotic site is the possibility to characterize the blood supply in the anastomotic region, the content of secretion, and the size and position of any leakage or pending defect. The latter can be recognized by supranormal fibrin secretion. This aspect is an indicator of a pending leakage ( fig. 1-3 ).
Endoscopic Therapy

Fibrin Glue
Fibrin glue is a two-component system consisting of fibrinogen and highly concentrated thrombin. Mixing these two components induces a polymerization from fibrinogen into a fibrin network. Herein, fibroblastic cells grow and induce wound healing and scarring. The first report about the successful endoscopic management of anastomotic leakages with fibrin glue was published by Groitl and Scheele in 1987 [3] . This method was one of the first options for the endoscopic management of anastomotic leakages. Later case series reported moderate success rates especially in mild cases [4] . Of note, the fibrin glue applications have to be repeated many times. The best results can be achieved in the case of small leakages or residual small fistulas. It is important to note that the mechanism of action is not mechanical but biological. The fibrin glue should be injected into the tissue and not just into the lumen of the fistula. It is a medical blood product from human donors. Thus, the application of fibrin glue bears a risk of infection (hepatitis and HIV) and informed consent of the patient is required.
Stenting
Self-expanding metal mesh stents were established to treat malignant stenosis. Nowadays, they are also used for the treatment of benign diseases. Since metal mesh stents are available with a coating, they have the potential of tightening fistulas and leakages. Since there is typically no stenosis at the anastomotic site, stents with wide diameters from 23 to 35 mm are used. Good results were achieved in terms of healing of leaking anastomoses. Feith et al. [5] reported on 115 consecutive patients with a leakage after esophagectomy or gastrectomy, with 70 of them achieving complete healing after stent implantation. The main problems were the high rate of stent migration (53%) and symptomatic strictures after stent removal (12%) as well as a high rate of re-interventions. In-hospital mortality was 9% in this series [5] .
Contrast swallowing and radiography are used as a control of the tightness of the anastomosis after stent implantation. Due to the non-tubular geometry of many anastomoses especially after gastrectomy, the stents cover the oral entrance very well but the distal end allows fluid to flow back outside of the stent to the anastomotic site. Once controlled endoscopically, the stent position may be seen in a conventional X-ray ( fig. 4) .
For choosing the proper stent for the individual patient, a variety of stents with different length and diameters should be available. Corresponding to the individual situation, a large flexible stent with a minimum diameter of 25 mm and a length of 10 cm may be used. Stents should be removed as early as possible to avoid migration and additional stenosis at the ends of the stent. Fixation with metal clips is an option for preventing stent migration ( fig. 5) .
Further adverse events of intraluminal stents in the upper gastrointestinal tract are arrosions of large vessels and major bleeding, penetrations of the stent into the trachea and airway obstruction, and even enlargement of the anastomotic leakage due to rough handling in the course of the stent placement procedure [6] . For special postoperative situations, e.g. sleeve gastrectomy, special stents are available.
Clipping
Clipping of anastomotic leakages follows a mechanical concept. Sufficient drainage of the infected area outside of the lumen is mandatory when employing this type of endoscopic therapy. The technique might be helpful in cases with a good strength of the gastrointestinal wall edges. Few reports describe the use of throughthe-scope clips for closure [6] . In the past years, more reports about experiences with the over-the-scope clip (OTSC) have been published. This powerful clip has bigger arms and can grasp more tissue. Furthermore, additional instruments can grasp the wound edges and pull them into the clip. An international multicenter study from 2014 reported on 188 patients (108 fistulae, 48 perforations, and 32 leaks) with good success rates [7] . The long-term success was significantly higher when OTSCs were applied as the primary therapy (primary 69.1% vs. rescue 46.9%; p = 0.004). In multivariate analysis, patients who received OTSC placement for perforations and leaks had significantly higher long-term success rates compared with those who had fistulae (odds ratio 51.4 and 8.36, respectively) [7] .
Endoscopic Vacuum-Assisted Closure Therapy
A very promising method to endoscopically manage anastomotic leakages is the endoscopic vacuum-assisted closure system (EndoVAC therapy).
Basic Principles of EndoVAC Therapy
The first report about vacuum therapy dates from Safronov in 1962 [8] . In the 1990s it became increasingly more applied in traumatology and for the treatment of infected wounds [9] . The permanent suction reduces wound secretion and edema, improves microcirculation, induces granulation of the wound, and decreases the wound size by retraction.
Special Aspects of EndoVAC Therapy in the Upper Gastrointestinal Tract
Because of the convincing results of vacuum therapy in the treatment of local infections, the adoption of this method for endo- scopic purposes was suggested. In 2008, Weidenhagen et al. [10] reported on EndoVAC treatment of anastomotic leakages after rectal resections. After the rapid spread of this new method, Loske and coworkers started to perform endoscopic vacuum therapy in patients with anastomotic leakages and sepsis in the upper gastrointestinal tract [11, 12] . The use of endo-sponges follows the same principles in the upper and lower gastrointestinal tract. Following endoscopic rinsing a sponge is placed in the cavity of the leakage. The sponge should be as small as possible but its diameter should guarantee that all parts of the wound are drained after the application of negative pressure. Furthermore, the sponge contains a drain which hauls out the exudate and ensures a permanent negative pressure. There is no evidence regarding the optimal pressure and the frequency of changing the sponge. Most authors recommend an exchange every 3 days and a negative pressure of 125 mm Hg.
Commercially available systems offer a prepared sponge with central drain that can be adapted to the individual shape of the lesion. Furthermore, the system contains an overtube, which facilitates the placement of the sponge. The sponge may also be placed into the intestinal lumen with therapeutic benefit, in particular if the leakage is too small to place the sponge through it (fig. 6 ).
The newest developments are tubes wrapped with fine porous films that apply the vacuum-assisted closure technique in narrow cavities [13, 14] .
The experience with techniques such as rubber band ligation or with suturing systems is limited to case reports and cannot be recommended as a clinical standard technique for the treatment of anastomotic leakages.
Nutrition Support
In critically ill patients, the nutritional status contributes to a successful treatment of anastomotic leakages. Permanent enteral nutrition is beneficial for wound healing. Thus, the placement of a feeding tube is part of the endoscopic management of anastomotic insufficiency. If percutaneous endoscopic gastrostomy is not an option, the placement of a nasojejunal feeding tube is a valuable endoscopic treatment alternative. In cases of intended vacuum therapy, the feeding tube should be placed first. If the placement of a stent is intended, the feeding tube has to be placed subsequently.
Conclusion
The successful treatment of anastomotic leakages and other septic complications at the site of operation necessitates endoscopic support. Individual good expertise and skills with endoscopic interventions as well as familiarity with the management of postsurgical complications are necessary [13] . A good communication and cooperation of surgeons and endoscopists as well as interdisciplinary decision making are necessary to optimize the therapy for the individual patient with anastomotic leakages after upper gastrointestinal surgery.
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